← 產業報告目錄

Protein Biomarkers Market, By Biomarker Type (Oncology Protein Biomarkers, Cardiac Protein Biomarkers, Inflammatory and Sepsis Protein Biomarkers, Neurology Protein Biomarkers, Autoimmune Protein Biomarkers, Metabolic Protein Biomarkers, and Others), By Application (Biomarker Discovery and Validation, Drug Discovery and Clinical Trial Support, Assay Development, Antibody Development, and Others), By End User (IVD and Diagnostic Assay Manufacturers, Pharmaceutical and Biotechnology Companies, CROs and Biomarker Testing Service Providers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

出版商 Coherent Market Insights出版日期 2026-07-24頁數 250報告編號 CMR-36ac7b8a0a

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global protein biomarkers market is estimated to be valued at USD 9,925.9 Mn in 2026 and is expected to reach USD 17,686.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033. Protein biomarkers are molecules in bodily fluid or tissue that help researchers, scientists, or clinicians measure the functional state of a tissue, monitor disease progression, or indicate normal/abnormal function or response to treatment. Protein biomarkers offer a valuable strategy for cancer, cardiovascular and neurological disorder detection and diagnoses, patient stratification, infectious disease, and therapy. The global protein biomarkers market is growing significantly as a result of recent developments and adoption of technologies such as proteomics, mass spectrometry, and next generation sequencing and the increase in the application of AI driven data analytics. The market consists of biomarker discovery and validation platforms, diagnostic assays, reagents and bioinformatics solutions, and it serves pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations, and academic research institutions, while also supporting the growing use of precision medicine. Market Dynamics The global protein biomarkers market is driven by increasing occurrence of cancer, cardiovascular disorders, diabetes and neurodegenerative conditions leading to a demand for quick and early detection and diagnosis. The development and launch of protein biomarker tests is gaining traction with enhanced precision medicine practices and the emergence of novel technologies including multiplex immunoassays, mass spectrometry, and the progress of proteomic technologies. Growing expenditure in biomarker discovery research are further accelerating the development and commercialization of protein biomarker-based diagnostics. However, a number of constraints are present in the market, such as high costs associated with biomarker discovery and validation, stringent regulatory requirements, and issues related to assay standardization and reproducibility. Nevertheless, expanding applications of liquid biopsy, integration of AI and machine learning in biomarker discovery, and increasing adoption of point-of-care diagnostics will offer new opportunities for growth in protein biomarkers market. Key Features of the Study • This report provides in-depth analysis of the global protein biomarkers market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global protein biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies, Inc., Merck KGaA, QIAGEN N.V., Bio-Rad Laboratories, Inc., Revvity, Inc., Bio-Techne Corporation, and Quanterix Corporation • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global protein biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein biomarkers market Market Segmentation • Biomarker Type Insights (Revenue, USD Mn, 2021 - 2033) o Oncology Protein Biomarkers o Cardiac Protein Biomarkers o Inflammatory and Sepsis Protein Biomarkers o Neurology Protein Biomarkers o Autoimmune Protein Biomarkers o Metabolic Protein Biomarkers o Others • Application Insights (Revenue, USD Mn, 2021 - 2033) o Biomarker Discovery and Validation o Drug Discovery and Clinical Trial Support o Assay Development o Antibody Development o Others • End User Insights (Revenue, USD Mn, 2021 - 2033) o IVD and Diagnostic Assay Manufacturers o Pharmaceutical and Biotechnology Companies o CROs and Biomarker Testing Service Providers o Others • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Hoffmann-La Roche Ltd. o Thermo Fisher Scientific Inc. o Abbott Laboratories o Agilent Technologies, Inc. o Merck KGaA o QIAGEN N.V. o Bio-Rad Laboratories, Inc. o Revvity, Inc. o Bio-Techne Corporation o Quanterix Corporation
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Protein Biomarkers Market, By Biomarker Type  Global Protein Biomarkers Market, By Application  Global Protein Biomarkers Market, By End User  Global Protein Biomarkers Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Protein Biomarkers Market, By Biomarker Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Oncology Protein Biomarkers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Cardiac Protein Biomarkers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Inflammatory and Sepsis Protein Biomarkers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Neurology Protein Biomarkers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Autoimmune Protein Biomarkers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Metabolic Protein Biomarkers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Protein Biomarkers Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Biomarker Discovery and Validation  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Drug Discovery and Clinical Trial Support  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Assay Development  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Antibody Development  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Protein Biomarkers Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o IVD and Diagnostic Assay Manufacturers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Pharmaceutical and Biotechnology Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o CROs and Biomarker Testing Service Providers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Protein Biomarkers Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o Hoffmann-La Roche Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Thermo Fisher Scientific Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Agilent Technologies, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck KGaA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o QIAGEN N.V.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bio-Rad Laboratories, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Revvity, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bio-Techne Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Quanterix Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 9. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Protein Biomarkers Market' - Global forecast to 2033
圖表清單 List of Tables & Figures
NA NA

提及公司

o Hoffmann-La Roche Ltd.o Thermo Fisher Scientific Inc.o Abbott Laboratorieso Agilent TechnologiesInc.o Merck KGaAo QIAGEN N.V.o Bio-Rad LaboratoriesInc.o RevvityInc.o Bio-Techne Corporationo Quanterix Corporation

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們